Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (7): 659-663.doi: 10.3969/j.issn.1000-6621.2021.07.004
Previous Articles Next Articles
ZHAO Guo-lian(), TAN Xiao-wen, CUI Xiao-li, DANG Li-yun
Received:
2021-02-01
Online:
2021-07-10
Published:
2021-07-09
Contact:
ZHAO Guo-lian
E-mail:774567495@qq.com
ZHAO Guo-lian, TAN Xiao-wen, CUI Xiao-li, DANG Li-yun. Analysis of gene polymorphism of Mycobacterium tuberculosis with negative MPT64 antigen in culture filtrate[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 659-663. doi: 10.3969/j.issn.1000-6621.2021.07.004
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.07.004
菌株 编号 | 分离时间 (年-月) | BACTEC MGIT 960液体培养 | 分枝杆菌 菌种鉴定 | MPT64 抗原检测 | MPT64基因 突变特征 | 表型特征 |
---|---|---|---|---|---|---|
1 | 2018-02 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
2 | 2018-04 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
3 | 2018-04 | + | MTB | 阴性 | IS6110插入 | 587位点插入1361 bp IS6110基因 |
4 | 2018-07 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
5 | 2018-08 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
6 | 2018-12 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
7 | 2019-03 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
8 | 2019-03 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
9 | 2019-06 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
10 | 2019-09 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
11 | 2019-10 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
12 | 2019-11 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
13 | 2019-11 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
14 | 2020-02 | + | MTB | 阴性 | 63 bp缺失 | 第197~259位核苷酸缺失,第66~86位氨基酸缺失 |
15 | - | + | MTB | 阳性 | 无 | 无 |
16 | 2020-02 | + | MTB | 阳性 | 无 | 无 |
[1] |
张宇晔, 侯东妮, 王苏珍, 等. 非结核分枝杆菌肺病临床分离株的菌种鉴定及临床特征分析. 微生物与感染, 2020, 15(3):172-178. doi: 10.3969/j.issn.1673-6184.2020.03.006.
doi: 10.3969/j.issn.1673-6184.2020.03.006 |
[2] |
Shenoy VP, Mukhopadhyay C. Rapid Immunochromatographic Test for the Identification and Discrimination of Mycobacterium tuberculosis Complex Isolates from Non-tuberculous Mycobacteria. J Clin Diagn Res, 2014, 8(4): DC13-5. doi: 10.7860/JCDR/2014/7098.4253.
doi: 10.7860/JCDR/2014/7098.4253 |
[3] |
Chikamatsu K, Aono A, Yamada H, et al. Comparative eva-luation of three immunochromatographic identification tests for culture confirmation of Mycobacterium tuberculosis complex. BMC Infect Dis, 2014, 14:54. doi: 10.1186/1471-2334-14-54.
doi: 10.1186/1471-2334-14-54 pmid: 24484470 |
[4] |
易俊莉, 杨新宇, 张洁, 等. 三种检测技术鉴别结核分枝杆菌复合群与非结核分枝杆菌的效能评价. 结核与肺部疾病杂志, 2020, 1(3):240-244. doi: 10.3969/j.issn.2096-8493.2020.03.007.
doi: 10.3969/j.issn.2096-8493.2020.03.007 |
[5] |
仇艳, 蒋毅, 刘海灿, 等. 中国结核分枝杆菌MPT64蛋白多态性及对MPT64抗原检测试剂盒的敏感性影响. 实用预防医学, 2015, 22(4):385-389. doi: 10.3969/j.issn.1006-3110.2015.04.001.
doi: 10.3969/j.issn.1006-3110.2015.04.001 |
[6] |
赵国连, 崔晓利, 康磊, 等. 荧光PCR探针熔解曲线技术检测涂阳患者痰标本中结核分枝杆菌耐药性的价值. 中国防痨杂志, 2019, 41(2):149-155. doi: 10.3969/j.issn.1000-6621.2019.02.006.
doi: 10.3969/j.issn.1000-6621.2019.02.006 |
[7] |
Yu MC, Chen HY, Wu MH, et al. Evaluation of the rapid MGIT TBc identification test for culture confirmation of Mycobacterium tuberculosis complex strain detection. J Clin Microbiol, 2011, 49(3):802-807. doi: 10.1128/JCM.02243-10.
doi: 10.1128/JCM.02243-10 URL |
[8] | 黄明翔, 张丽水, 陈新朝, 等. 胶体金法结合涂片形态学特征快速鉴别结核分枝杆菌复合群的应用评价. 中国防痨杂志, 2012, 34(12):830-834. |
[9] |
Gomathi NS, Devi SM, Lakshmi R, et al. Capilia test for identification of Mycobacterium tuberculosis in MGIT TM-positive cultures. Int J Tuberc Lung Dis, 2012, 16(6):788-792. doi: 10.5588/ijtld.11.0356.
doi: 10.5588/ijtld.11.0356 URL |
[10] |
Ngamlert K, Sinthuwattanawibool C, McCarthy KD, et al. Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Trop Med Int Health, 2009, 14(7):748-753. doi: 10.1111/j.1365-3156.2009.02284.x.
doi: 10.1111/j.1365-3156.2009.02284.x URL |
[11] |
Wang JY, Lee LN, Lai HC, et al. Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis, 2007, 59(4):395-399. doi: 10.1016/j.diagmicrobio.2007.06.010.
doi: 10.1016/j.diagmicrobio.2007.06.010 URL |
[12] |
Sanoussi CN, de Jong BC, Odoun M, et al. Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex. J Med Microbiol, 2018, 67(12):1718-1727. doi: 10.1099/jmm.0.000846.
doi: 10.1099/jmm.0.000846 pmid: 30388066 |
[13] | 易松林, 郭婧玮, 陈忠南, 等. MPT抗原阴性的结核分枝杆菌复合群临床分离株mpt64突变特征分析. 实用预防医学, 2020, 27(6):649-651. |
[14] |
Jiang Y, Liu H, Wang H, et al. Polymorphism of antigen MPT64 in Mycobacterium tuberculosis strains. J Clin Microbiol, 2013, 51(5):1558-1562. doi: 10.1128/JCM.02955-12.
doi: 10.1128/JCM.02955-12 pmid: 23390287 |
[15] |
Chew KL, Lin RTP, Teo JWP. MPT64 gene mutations leading to non-reactivity on a rapid immunochromatographic assay. J Infect Dev Ctries, 2017, 11(4):371-373. doi: 10.3855/jidc.8768.
doi: 10.3855/jidc.8768 URL |
[16] |
Singh K, Kumari R, Tripathi R, et al. Mutation in MPT64 gene influencing diagnostic accuracy of SD Bioline assay (capilia). BMC Infect Dis, 2019, 19(1):1048. doi: 10.1186/s12879-019-4671-2.
doi: 10.1186/s12879-019-4671-2 URL |
[17] |
Hillemann D, Rüsch-Gerdes S, Richter E. Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis, 2005, 9(12):1409-1411.
pmid: 16466066 |
[1] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[2] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[3] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[4] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[5] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[6] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[7] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[8] | Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong. The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65. |
[9] | Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76. |
[10] | Geng Zimei, Wang Chaohong, Long Sibo, Zheng Maike, Shi Yiheng, Sun Yong, Zhao Yan, Wang Guirong. Analysis of bacteriological positivity and rifampicin resistance in patients with severe pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1050-1055. |
[11] | Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068. |
[12] | Wang Fei, Hua Duo, Guo Jianjian, Liu Chang, Han Lu, Ren Yi. Characteristic analysis of non-tuberculous mycobacterial pulmonary disease patients in Wuhan area from 2021 to 2023 [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1069-1076. |
[13] | Palidanguli Abudureheman, Wang Senlu, Gulina Badeerhan, Wang Le, Zulikatiayi Abudula, Wang Xinqi, Maiwulajiang Yimamu, Wang Xijiang. Distribution of Mycobacterium tuberculosis genotypes in Kashgar region and their association with clinical characteristics of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1077-1082. |
[14] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[15] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||